Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/BENZAC SPOTS TREATMENT

Approved

STANDARD

BENZAC SPOTS TREATMENT

Laboratoires Galderma🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e986ade42fa686d9
Company: Laboratoires Galderma
Type: Standard

Approval Details

Approval Id: e986ade42fa686d9
Drug Approval Philippines Name: BENZAC SPOTS TREATMENT
Product Name: BENZAC SPOTS TREATMENT
Registration Number: DR-XY16211
Brand Name: BENZAC SPOTS TREATMENT
Generic Name: BENZOYL PEROXIDE
Dosage Form: Gel
Dosage Strength: 50mg/g (5% w/w)
Manufacturer: Laboratoires Galderma
Importer: GALDERMA PHILIPPINES, INC.
Company Detail Path: /organization/laboratoires-galderma
Issuance Date: 07 December 2021
Expiry Date: 09 December 2026
Pharmacologic Category: Keratolytic
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e986ade42fa686d9

Type

Standard

Back to Philippines FDA Approvals

BENZAC SPOTS TREATMENT - Philippines FDA Drug Approval Details